PlainRecalls
ModerateClass IITerminated

FDA Devices recall · Reported January 25, 2017

Great Basin Staph lD/R Blood Culture Panel The Great Basin Staph lD/R Blood Culture Panel is a qualitative, multiplex in vitro diagnostic assay intended for use with the P4500 PortraitrM Analyzer System. The Staph lD/R Blood Culture Panel is capable of simultaneous detection and identification ol Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus lugdunensrs and various Staphylococcus species to the genus level and the detection of the mecA gene for methicillin resistance from

The Great Basin Staph ID/R Panel is being recalled because the S. aureus probe could potentially result in a false positive.

Recall #
Z-1051-2017
Affected scope
32 Kits (320 individual disposable cartridges)
Initiated
December 12, 2016
Verify with FDA Devices →
View my saved recalls

Great Basin Scientific, Inc. recalled Great Basin Staph lD/R Blood Culture Panel The Great Basin Staph lD/R Blood Culture Pa… - a moderate-severity action.

Great Basin Staph lD/R Blood Culture Panel The Great Basin Staph lD/R Blood Culture Pa… was recalled by Great Basin Scientific, Inc. in January 25, 2017. Reason: The Great Basin Staph ID/R Panel is being recalled because the S. aureus probe could potentially result in a …. Check the official notice for the remedy. Verify recall #Z-1051-2017 with the FDA Devices before acting.

The recall

Great Basin Scientific, Inc. issued this moderate-severity FDA Devices recall-The Great Basin Staph ID/R Panel is being recalled because the S. aureus probe could potentially result in a ….

Moderate
severity level
Class II
classification
January 25, 2017
reported

Sourced from official FDA Devices enforcement records. Verify recall #Z-1051-2017 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 6 from FDA Devices - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Medical Devices recalls over time

Where this recall sits in its category - 41,021 medical devices recalls on record

01,0002,0003,0004,000 20052008201120142017202020232026 1,947
Severity1906864652High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Great Basin Staph lD/R Blood Culture Panel The Great Basin Staph lD/R Blood Culture Panel is a qualitative, multiplex in vitro diagnostic assay intended for use with the P4500 PortraitrM Analyzer System. The Staph lD/R Blood Culture Panel is capable of simultaneous detection and identification ol Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus lugdunensrs and various Staphylococcus species to the genus level and the detection of the mecA gene for methicillin resistance from patient positive blood culture specimens.

Reason for recall

The Great Basin Staph ID/R Panel is being recalled because the S. aureus probe could potentially result in a false positive.

Recall Profile

Structured summary of the FDA Devices recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Terminated
Recall number Z-1051-2017
Date reported January 25, 2017
Date initiated December 12, 2016
Recalling firm Great Basin Scientific, Inc.
Firm location Salt Lake City, UT
Affected scope 32 Kits (320 individual disposable cartridges)
Distribution US Nationwide Distribution.

Profile values are sourced directly from the official FDA Devices enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (Z-1051-2017) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Devices before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Devices record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Great Basin Staph lD/R Blood Culture Panel The Great Basin Staph lD/R Blood Culture Panel is a qualitative, multiplex in vitro diagnostic assay intended for use with the P4500 PortraitrM Analyzer System. The Staph lD/R Blood Culture Panel is capable of simultaneous detection and identification ol Staphylococcus aureus, Staphylococcus epidermidis, Staphylococcus lugdunensrs and various Staphylococcus species to the genus level and the detection of the mecA gene for methicillin resistance from patient positive blood culture specimens.. Recalled by Great Basin Scientific, Inc.. Units affected: 32 Kits (320 individual disposable cartridges).
Why was this product recalled?
The Great Basin Staph ID/R Panel is being recalled because the S. aureus probe could potentially result in a false positive.
Which agency issued this recall?
This recall was issued by the FDA Devices on January 25, 2017. Severity: Moderate. Recall number: Z-1051-2017.
Where was the recalled product distributed?
Distribution: US Nationwide Distribution..
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Compare this recall with GORE VIABIL Short Wire Biliary Endoprosthesis, Model No. VS… → · All Medical Devices recalls

This recall: FDA Devices, reported January 25, 2017. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026